Abbott Laboratories (ABT) News
Filter ABT News Items
ABT News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ABT News Highlights
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
-
404 Page not found Error: Page not found
The requested URL was not found on this server.
Latest ABT News From Around the Web
Below are the latest news stories about ABBOTT LABORATORIES that investors may wish to consider to help them evaluate ABT as an investment opportunity.
AngioDynamics Stock Up on Q2 Earnings Beat, Gross Margin DeclinesANGO registers overall strong top-line results on a pro-forma basis in second-quarter fiscal 2025, driven by strength in the Med Tech business. |
Abbott Stock Trades at a Discounted P/B Value: To Buy or Not to Buy?ABT gains a key position in point-of-care testing, focusing on Infectious Disease, Cardiometabolic & Informatics, Toxicology and Consumer Diagnostics. |
Insiders At Abbott Laboratories Sold US$3.0m In Stock, Alluding To Potential WeaknessOver the past year, many Abbott Laboratories ( NYSE:ABT ) insiders sold a significant stake in the company which may... |
BDSX Stock Rises After Publication of Study Data for Nodify CDT TestBiodesix announces positive study data for its Nodify CDT blood-based lung nodule test published in CHEST Pulmonary Journal. |
Here's Why You Should Retain BDX Stock in Your Portfolio for NowBD's robust product portfolio and a few strategic deals raise optimism about the stock. However, stiff competition and macroeconomic volatility are concerns. |
Abbott (ABT) Stock Falls Amid Market Uptick: What Investors Need to KnowIn the latest trading session, Abbott (ABT) closed at $113.04, marking a -0.69% move from the previous day. |
Is Abbott Laboratories (NYSE:ABT) the Best January Dividend Stock to Buy?We recently compiled a list of the 10 Best January Dividend Stocks To Buy. In this article, we are going to take a look at where Abbott Laboratories (NYSE:ABT) stands against the other January dividend stocks. In 2024, dividend stocks fell short of investor expectations, largely due to the continuing AI boom and a heightened interest […] |
Abbott Laboratories (NYSE:ABT) Could Easily Take On More DebtHoward Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of... |
Are Medical Stocks Lagging Abbott Laboratories (ABT) This Year?Here is how Abbott (ABT) and Acurx Pharmaceuticals, Inc. (ACXP) have performed compared to their sector so far this year. |
Abbott Hosts Conference Call for Fourth-Quarter EarningsAbbott (NYSE: ABT) will announce its fourth-quarter 2024 financial results on Wednesday, Jan. 22, before the market opens. |